Nathan Caffo

Keine laufenden Positionen mehr

57 Jahre

Health Technology

Consumer Services

Profil

Nathan Caffo served as the President & Chief Executive Officer at Presage Biosciences, Inc. from 2009 to 2018.
He then worked as the Chief Business Officer at ALX Oncology Holdings, Inc. from 2018 to 2020.
Currently, he is the Chief Business Officer at Candel Therapeutics, Inc. starting from 2020.
Mr. Caffo completed his undergraduate degree at The Pennsylvania State University.

Ehemalige bekannte Positionen von Nathan Caffo

Unternehmen	Position	Ende
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	01.04.2023
ALX ONCOLOGY HOLDINGS INC.	Corporate Officer/Principal	01.09.2020
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Vorstandsvorsitzender	17.07.2018

Sehen Sie sich die Erfahrung von Nathan Caffo im Detail an

Ausbildung von Nathan Caffo

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Nathan Caffo im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Health Technology
The Pennsylvania State University The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology